Company profile: Zyvex
1.1 - Company Overview
Company description
- Provider of molecular nanotechnology innovations focused on developing atomically precise manufacturing. Founded in 1997 as the first molecular nanotechnology company; by 2007 its research had been commercialized into several products and it later restructured into separate companies to focus on product lines.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Zyvex
N2 Biomedical
HQ: United States
Website
- Description: Provider of coating, anodizing, and printing services for medical devices—including guidewires, core wires, hypo tubes, and forming mandrels—for global healthcare and medical device companies. Collaborates from concept to commercialization, offering flexible prototype work and high-volume production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full N2 Biomedical company profile →
BeDimensional
HQ: Italy
Website
- Description: Provider of graphene and other two-dimensional materials with few atomic layers. Offers graphene-based solutions for lithium-ion batteries to improve performance and longevity; graphene-based lubricants to reduce friction and energy consumption; and B-Leaf h-BN coatings, including concentrates for aqueous, high/medium, and medium polarity systems, plus an h-BN-based anticorrosion paint.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BeDimensional company profile →
Zynerba Pharmaceuticals
HQ: United States
Website
- Description: Provider of innovative transdermal cannabinoid treatments for neuropsychiatric disorders, developing proprietary dermal solutions and therapeutic candidates using modern drug delivery technology. Offers Zygel (ZYN002 cannabidiol gel) for Fragile X syndrome and 22q11.2 deletion syndrome, and conducts clinical trials across various countries to assess its safety and efficacy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zynerba Pharmaceuticals company profile →
Dreamweaver
HQ: United States
Website
- Description: Provider of nonwoven battery separators made from a combination of nanofibers and microfibers, enabling 300% higher power through increased electricity transmission in batteries and improving power in electric vehicles, power tools, and other high-power applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dreamweaver company profile →
Naco Technologies
HQ: Latvia
Website
- Description: Provider of nano-coating technologies, developing, manufacturing, and supplying high-performance multilayer and multicomponent coatings for equipment in the tooling, automotive, aerospace, and micro-chip industries. Products include oil-enhanced, wear-protective, and thermal coatings, serving customers worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Naco Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Zyvex
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Zyvex
2.2 - Growth funds investing in similar companies to Zyvex
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Zyvex
4.2 - Public trading comparable groups for Zyvex
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →